Dow Up 0.11% Nasdaq Up 0.50%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.35 Up 0.07(5.47%) Aug 29, 4:00PM EDT
|After Hours : 1.40 Up 0.05 (3.70%) Aug 29, 7:43PM EDT
Prev Close:1.28
Open:1.30
Bid:1.35 x 700
Ask:1.45 x 3200
1y Target Est:3.10
Beta:2.28
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.28 - 1.37
52wk Range:1.18 - 5.19
Volume:2,092,946
Avg Vol (3m):2,535,440
Market Cap:190.41M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXUp 5.47%190.41M
AZNUp 2.38%96.00B
GSKUp 0.47%117.94B
PFEUp 0.03%186.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback